Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

OBJECTIVES: We assessed the impact of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following administration of the 23-valent pneumococcal polysaccharide vaccine (PPV23). METHODS: A total of 190 patients with rheumatoid arthritis (RA) received P...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Ueki, Yukitaka, Akeda, Yukihiro, Hirakata, Naoyuki, Oribe, Motohiro, Shiohira, Yoshiki, Hidaka, Toshihiko, Oishi, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711492/
https://www.ncbi.nlm.nih.gov/pubmed/23345600
http://dx.doi.org/10.1136/annrheumdis-2012-202658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711492/
https://www.ncbi.nlm.nih.gov/pubmed/23345600
http://dx.doi.org/10.1136/annrheumdis-2012-202658

Ejemplares similares